Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

The effectiveness and safety of acupuncture for poor semen quality in infertile males: a systematic review and meta-analysis.

Jerng UM, Jo JY, Lee S, Lee JM, Kwon O.

Asian J Androl. 2014 Nov-Dec;16(6):884-91. doi: 10.4103/1008-682X.129130. Review.

3.

Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta-analysis of randomized and observational studies.

Hutton B, Joseph L, Yazdi F, Tetzlaff J, Hersi M, Kokolo M, Fergusson N, Bennett A, Buenaventura C, Fergusson D, Tricco A, Strauss S, Moher D, Knoll G.

Syst Rev. 2014 Feb 22;3:16. doi: 10.1186/2046-4053-3-16.

4.

Failure or success of electronic search strategies to identify adverse effects data.

Golder S, Loke YK.

J Med Libr Assoc. 2012 Apr;100(2):130-4. doi: 10.3163/1536-5050.100.2.012. No abstract available.

5.

Principles for defining adverse events in behavioral intervention research: lessons from a family-focused adolescent drug abuse trial.

Horigian VE, Robbins MS, Dominguez R, Ucha J, Rosa CL.

Clin Trials. 2010 Feb;7(1):58-68. doi: 10.1177/1740774509356575.

6.

Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.

7.

Focus on headache as an adverse reaction to drugs.

Ferrari A, Spaccapelo L, Gallesi D, Sternieri E.

J Headache Pain. 2009 Aug;10(4):235-9. doi: 10.1007/s10194-009-0127-1. Epub 2009 Jun 4. Review.

8.

Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention.

Ethgen M, Boutron I, Steg PG, Roy C, Ravaud P.

Trials. 2009 May 4;10:29. doi: 10.1186/1745-6215-10-29. Review.

9.

What is "quality of evidence" and why is it important to clinicians?

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch√ľnemann HJ; GRADE Working Group.

BMJ. 2008 May 3;336(7651):995-8. doi: 10.1136/bmj.39490.551019.BE. Review. No abstract available.

11.

The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.

Lefebvre J, Poirier L, Poirier P, Turgeon J, Lacourciere Y.

Br J Clin Pharmacol. 2007 May;63(5):575-82. Epub 2006 Nov 10.

12.

What is the best evidence for determining harms of medical treatment?

Vandenbroucke JP.

CMAJ. 2006 Feb 28;174(5):645-6. No abstract available.

13.

Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Papanikolaou PN, Christidi GD, Ioannidis JP.

CMAJ. 2006 Feb 28;174(5):635-41.

14.

Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.

Reisler RB, Murphy RL, Redfield RR, Parker RA.

J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):159-66.

Supplemental Content

Support Center